by David Roach, posted Thursday, March 31, 2016 (8 years ago)
WASHINGTON (BP) -- The Food and Drug Administration has updated its guidelines concerning the abortion drug mifepristone, allowing women to take it later in pregnancy and with reduced medical supervision.
The New York Times called the update "an unequivocal victory for abortion rights advocates."
Previously, women were permitted to take mifepristone (formerly known as RU-486) up to the seventh week of pregnancy, but that has been extended to 10 weeks. ... Read More